United States Plasma Fractionation Market Overview
Base Year: 2023
Historical Years: 2018-2023
Forecast Years: 2024-2032
Market Growth Rate: 7.80% (2024-2032)
The U.S. plasma fractionation market is expanding rapidly, driven by increasing demand for plasma-derived therapies and advancements in fractionation technology. This growth is fueled by the growing focus on patient care and the development of innovative plasma-based products. According to the latest report by IMARC Group, the market is projected to grow at a CAGR of 7.80% from 2024 to 2032.
United States Plasma Fractionation Market Trends and Drivers:
The United States plasma fractionation market is experiencing increasing demand for plasma-derived therapies. As advancements in healthcare continue, the market is seeing a growing focus on developing new treatments for immune disorders, hemophilia, and other plasma-related conditions. Technological innovations, particularly in fractionation processes, are helping manufacturers improve the yield and quality of plasma-derived products.
Additionally, the rising prevalence of chronic diseases and the aging population are contributing to the expanding need for plasma-based therapies, which are often used to treat immune deficiencies and clotting disorders. Regulatory support and government initiatives aimed at ensuring a stable supply of plasma are also encouraging growth in this sector.
Furthermore, the growing trend toward automation in plasma fractionation facilities is improving efficiency and reducing production costs, further driving market expansion. Companies are also investing in R&D to improve the safety and efficacy of plasma-based treatments, which is expected to shape the future of this market.
The United States plasma fractionation market is primarily driven by the increasing use of plasma-derived therapies in treating a wide range of medical conditions. One of the key drivers is the rising incidence of immune disorders and bleeding conditions, which require treatments derived from plasma fractions, such as immunoglobulins and clotting factors. This demand is expected to continue growing as more patients are diagnosed with these conditions.
The aging population is another factor driving the market, as elderly individuals are more prone to immune deficiencies and other conditions that benefit from plasma-based therapies. In addition, the shift toward personalized medicine, where treatments are tailored to individual patient needs, is boosting the demand for specific plasma-derived products. Advances in plasma collection and processing techniques are also improving the availability and quality of these therapies.
Furthermore, government initiatives aimed at increasing plasma donation and ensuring a stable plasma supply are playing a significant role in the market’s growth. Moreover, the development of recombinant alternatives to plasma-derived therapies is creating competition in the market and also pushing innovation in plasma fractionation technologies to meet evolving healthcare needs.
United States Plasma Fractionation Industry Segmentation:
The report has segmented the market into the following categories:
Product Insights:
- Immunoglobulins
- Albumin
- Coagulation factor VIII
- Coagulation factor IX
Sector Insights:
- Private Sector
- Public Sector
Application Insights:
- Neurology
- Immunology
- Hematology
- Others
End User Insights:
- Hospitals and Clinics
- Clinical Research Laboratories
- Academic Institutes
Regional Insights:
- Northeast
- Midwest
- South
- West
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
Key highlights of the Report:
- Market Performance (2018-2023)
- Market Outlook (2024-2032)
- COVID-19 Impact on the Market
- Porter’s Five Forces Analysis
- Strategic Recommendations
- Historical, Current and Future Market Trends
- Market Drivers and Success Factors
- SWOT Analysis
- Structure of the Market
- Value Chain Analysis
- Comprehensive Mapping of the Competitive Landscape
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
Ask analyst for your customized sample: https://www.imarcgroup.com/request?type=report&id=20578&flag=F
Browse more research report:
| U.S. Soda Ash Market size reached 6.3 Million Tons in 2023. Looking forward, IMARC Group expects the market to reach 6.9 Million Tons by 2032. |
| U.S. Football Market size is projected to exhibit a growth rate (CAGR) of 4.29% during 2024-2032. |
| U.S. Fertilizer Market size is projected to exhibit a growth rate (CAGR) of 4.73% during 2024-2032. |
| U.S. Orthopedic Braces And Support Market size is projected to exhibit a growth rate (CAGR) of 4.71% during 2024-2032. |
| U.S. Neuromodulation Market size is projected to exhibit a growth rate (CAGR) of 11.5% during 2024-2032. |
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145
